Determination of Favipiravir in Human Blood Plasma by HPLC-MS/MS

Determination of Favipiravir in Human Blood Plasma by HPLC-MS/MS

Introduction. Favipiravir is one of the most well-known broad-spectrum drugs against many RNA viruses, including the severe acute respiratory syndrome virus 2 [severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)]. Due to its structure, favipiravir is embedded in the RNA of the virus and blo...

Full description

Saved in:
Bibliographic Details
Main Authors: T. N. Komarov, P. A. Karpova, O. A. Archakova, D. S. Shchelgacheva, P. K. Karnakova, N. S. Bagaeva, K. Ya. Zaslavskaya, P. A. Bely, I. E. Shohin
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2023-09-01
Series:Разработка и регистрация лекарственных средств
Subjects:
favipiravir
human blood plasma
validation
covid-19
hplc-ms/ms
pharmacokinetics
bioequivalence
Online Access:https://www.pharmjournal.ru/jour/article/view/1562
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.pharmjournal.ru/jour/article/view/1562

Similar Items